China lifts ban on prenatal genetic testing

Print Friendly, PDF & Email

The mainland has lifted the controversial ban on medical diagnostic products that can help detect birth defects in unborn children.

The China Food and Drug Administration (CFDA) on Monday approved the registration of genomics company BGI’s sequencers — which help map out the sequence of a person’s genetic code, which in turn determine traits such as eye colour and skin colour or even the propensity to certain diseases.

The medical devices, called second-generation gene sequencing diagnostic products, are used for non-invasive tests on the foetus to detect genetic diseases such as Down’s syndrome.

The CFDA also approved diagnostic kits for “high-risk” pregnant women, such as those older than 35.

Such diagnostic products were introduced in China in 2011, initially for prenatal testing, but later extended to early detection of cancer and other diseases.

But last February, the government banned all medical applications of “gene-sequencing technology products,” claiming that some medical institutes were charging extortionate fees, and that it was too difficult to regulate the quality of the services.

Read the full, original story: China approves DNA-sequencing devices to detect genetic defects in unborn babies

Outbreak Featured
Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

There are many autoimmune diseases, and taken together they affect as much as 4.5 percent of the world’s population. This ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.